NCT00516672View on ClinicalTrials.gov

Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 10, 2007

Primary Completion Date

August 30, 2010

Study Completion Date

October 14, 2015

Conditions

Carcinoma, Renal Cell

Interventions

DRUG

pazopanib

Pazopanib oral tablet

DRUG

Lapatinib

Lapatinib oral tablet

Trial Locations (2)

466-8560

GSK Investigational Site, Aichi

350-1298

GSK Investigational Site, Saitama

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY